Rutgers, the State University of New Jersey
Bristol Myers Squibb US Field Medical Neuroscience and Medical Evidence Generati
Rutgers, the State University of New Jersey, Lawrenceville, New Jersey, United States
1 position(s) for US Field Medical Neuroscience and Medical Evidence Generation
Fellowship Position Office Location:
(Hybrid) 3401 Princeton Pike, Lawrenceville, NJ 08648 POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This
2-year
Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and
Bristol Myers Squibb . Program emphasis is in
US Field Medical Neuroscience and Medical Evidence Generation . This
2-year
Fellowship provides a unique opportunity to gain expertise in multiple dimensions of the medical affairs function in the neuroscience space. During their first year, the fellow will join the US Field Medical Neuroscience team and participate in key projects, critical to the success of new product/indication launches and currently approved products across assets within the Neuroscience organization. The fellow will gain an appreciation for core Field Medical competencies spanning field training, resource creation, operations, and thought leader (TL)/ investigator engagement. The fellow will have the opportunity to learn the intricacies of the MSL role via training, field rides, and scientific congress attendance. In their second year, the fellow will join the MEG team and contribute to the development and implementation of the Integrated Evidence Plan (IEP) and interact with the different modalities of evidence generation (investigator-sponsored studies, interventional and noninterventional company-sponsored trials, collaborative research, and exploratory analysis among others). The fellow will focus on the science and strategy of MEG generated studies, learning various aspects of clinical studies (Phase IIIb/IV) including study design, initiation, maintenance, and closure activities. US FIELD MEDICAL NEUROSCIENCE Serve as an integral part of the Field Medical Neuroscience Strategy and Operations team and key contributor for field medical planning, stakeholder communications, MSL training, and launch/life-cycle management projects Gain product and therapeutic expertise via MSL trainings, validations, and assessments in Neuroscience as foundational knowledge to apply to various projects and activities Collaborate with home office medical, medical learning, and field matrix teams to assist in the development of training initiatives and medical resources, including opportunity for stretch projects with these teams Contribute on innovative tactics and/or platforms to elevate MSL development and productivity in the field including resource launches, technology updates, and serving as point of contact for MSL troubleshooting Interact with external TLs throughout the fellowship year on field rides with MSLs and activities at scientific congresses. The Fellow will have the opportunity to accompany MSLs on field rides and virtual interactions to gain an understanding of diverse experiences with TLs and study investigators at congresses the fellow will experience the responsibilities of a MSL including presenting BMS data, competitive intelligence coverage, medical booth support, and gathering insights from thought leaders The fellow will collaborate across the cross-functional matrix team, including commercial, medical affairs, and other key stakeholders, to align on strategic priorities and drive cross-functional excellence in the field MEDICAL EVIDENCE GENERATION (MEG) Support the development, tracking and maintenance of Integrated Evidence Plans (IEPs) that reflect asset strategy, market priorities and medical evidence generation support in partnership with the Global Medical Disease Team and cross-functional teams including Global Drug Development (GDD), Translational Development, Health Economics and Outcomes Research (HEOR), and others Co-develop Areas of Interest (AOI) based on key open data questions (ODQ) identified in the IEP with market input in collaboration with the Global Medical Disease Teams Assist with the scientific aspects of the ongoing Investigator-sponsored Research (ISR) book of work and interface with all key stakeholders across the matrix Conduct regular book of work reviews in partnership with GDO (Global Development Operations) with key medical and development stakeholders, under their remit. Identify studies at risk for failing to meet timelines and negotiated mitigation plans with key internal stakeholders and investigators Assist in the reviews of concepts through RFP (Request for Proposals) process, as appropriate, including providing context for ongoing book of work, area of interest development, and upcoming data read-outs On MAST studies: work closely with the CTL (Clinical Trial Lead) and study team in making study-specific recommendations, providing clinical research expertise, presenting protocol specific topics, responding to health authority requests, and supporting the team at various therapeutic area conferences On CRCs (Clinical Research Collaboration): lead protocol development and trial activation in close collaboration with external investigators to align with the IEP and BMS’s strategic imperatives Support the study team in comprehensive clinical data review and analysis via available data review tools such as patient profiles, data review reports, and data listings University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit our website:
without links
The RPIF Program application portal opens at 12 PM ET on October 8th . Initial interviews will be conducted on a rolling basis virtually (video conference) starting October 20th. To apply, candidates MUST use the RPIF website (to create a RPIF Candidate Account and upload the required application materials) by the dates noted below. Remember that the application process is on a rolling basis, so earlier is better. Please see our website for additional important recruitment information and dates. Initial offers will not be made until December 12th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers. Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status. Candidate Checklist: Create an RPIF Candidate Account starting now. Upload RPIF Application Materials to RPIF Candidate Account starting October 8th, 2025. Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and Curriculum Vitae (CV) by October 17th, 2025. Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1st, 2025. RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date. As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas. Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law. Other commitments can be found at the link below:
please remove links
#J-18808-Ljbffr
(Hybrid) 3401 Princeton Pike, Lawrenceville, NJ 08648 POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This
2-year
Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and
Bristol Myers Squibb . Program emphasis is in
US Field Medical Neuroscience and Medical Evidence Generation . This
2-year
Fellowship provides a unique opportunity to gain expertise in multiple dimensions of the medical affairs function in the neuroscience space. During their first year, the fellow will join the US Field Medical Neuroscience team and participate in key projects, critical to the success of new product/indication launches and currently approved products across assets within the Neuroscience organization. The fellow will gain an appreciation for core Field Medical competencies spanning field training, resource creation, operations, and thought leader (TL)/ investigator engagement. The fellow will have the opportunity to learn the intricacies of the MSL role via training, field rides, and scientific congress attendance. In their second year, the fellow will join the MEG team and contribute to the development and implementation of the Integrated Evidence Plan (IEP) and interact with the different modalities of evidence generation (investigator-sponsored studies, interventional and noninterventional company-sponsored trials, collaborative research, and exploratory analysis among others). The fellow will focus on the science and strategy of MEG generated studies, learning various aspects of clinical studies (Phase IIIb/IV) including study design, initiation, maintenance, and closure activities. US FIELD MEDICAL NEUROSCIENCE Serve as an integral part of the Field Medical Neuroscience Strategy and Operations team and key contributor for field medical planning, stakeholder communications, MSL training, and launch/life-cycle management projects Gain product and therapeutic expertise via MSL trainings, validations, and assessments in Neuroscience as foundational knowledge to apply to various projects and activities Collaborate with home office medical, medical learning, and field matrix teams to assist in the development of training initiatives and medical resources, including opportunity for stretch projects with these teams Contribute on innovative tactics and/or platforms to elevate MSL development and productivity in the field including resource launches, technology updates, and serving as point of contact for MSL troubleshooting Interact with external TLs throughout the fellowship year on field rides with MSLs and activities at scientific congresses. The Fellow will have the opportunity to accompany MSLs on field rides and virtual interactions to gain an understanding of diverse experiences with TLs and study investigators at congresses the fellow will experience the responsibilities of a MSL including presenting BMS data, competitive intelligence coverage, medical booth support, and gathering insights from thought leaders The fellow will collaborate across the cross-functional matrix team, including commercial, medical affairs, and other key stakeholders, to align on strategic priorities and drive cross-functional excellence in the field MEDICAL EVIDENCE GENERATION (MEG) Support the development, tracking and maintenance of Integrated Evidence Plans (IEPs) that reflect asset strategy, market priorities and medical evidence generation support in partnership with the Global Medical Disease Team and cross-functional teams including Global Drug Development (GDD), Translational Development, Health Economics and Outcomes Research (HEOR), and others Co-develop Areas of Interest (AOI) based on key open data questions (ODQ) identified in the IEP with market input in collaboration with the Global Medical Disease Teams Assist with the scientific aspects of the ongoing Investigator-sponsored Research (ISR) book of work and interface with all key stakeholders across the matrix Conduct regular book of work reviews in partnership with GDO (Global Development Operations) with key medical and development stakeholders, under their remit. Identify studies at risk for failing to meet timelines and negotiated mitigation plans with key internal stakeholders and investigators Assist in the reviews of concepts through RFP (Request for Proposals) process, as appropriate, including providing context for ongoing book of work, area of interest development, and upcoming data read-outs On MAST studies: work closely with the CTL (Clinical Trial Lead) and study team in making study-specific recommendations, providing clinical research expertise, presenting protocol specific topics, responding to health authority requests, and supporting the team at various therapeutic area conferences On CRCs (Clinical Research Collaboration): lead protocol development and trial activation in close collaboration with external investigators to align with the IEP and BMS’s strategic imperatives Support the study team in comprehensive clinical data review and analysis via available data review tools such as patient profiles, data review reports, and data listings University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit our website:
without links
The RPIF Program application portal opens at 12 PM ET on October 8th . Initial interviews will be conducted on a rolling basis virtually (video conference) starting October 20th. To apply, candidates MUST use the RPIF website (to create a RPIF Candidate Account and upload the required application materials) by the dates noted below. Remember that the application process is on a rolling basis, so earlier is better. Please see our website for additional important recruitment information and dates. Initial offers will not be made until December 12th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers. Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status. Candidate Checklist: Create an RPIF Candidate Account starting now. Upload RPIF Application Materials to RPIF Candidate Account starting October 8th, 2025. Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and Curriculum Vitae (CV) by October 17th, 2025. Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1st, 2025. RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date. As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas. Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law. Other commitments can be found at the link below:
please remove links
#J-18808-Ljbffr